Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-09-27 13:10:54 - browse：219

Adam's take main illustration — Molly Ferguson/STAT

The eye disease physician in charge of a committee that flagged a rare but severe side effect involving a newly approved drug from Apellis Pharmaceuticals has financial ties to a competing drugmaker. The conflict raises questions about his supervision of an emerging safety issue for patients and its impact on the financial health of Apellis.

Peter Kaiser, a retinal disease expert who runs the Cole Eye Institute at the Cleveland Clinic, failed to report consulting fees and stock ownership in Iveric Bio on a financial disclosure form maintained by the American Society of Retina Specialists, or ASRS. Iveric Bio is developing a treatment for geographic atrophy, a common, age-related cause of vision loss and the same indication for which the Apellis drug was approved.

The financial conflict, which was undisclosed until after Kaiser was contacted about it by STAT, is relevant because Kaiser also chairs a committee of the ASRS responsible for monitoring the safety of retina drugs and devices. On July 15, Kaiser’s committee sent a letter to member doctors, alerting them to reports of eye inflammation in people receiving injections of Syfovre, the treatment recently approved and launched by Apellis.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： No plane should take off without an EpiPen onboard

hotspot

WSS

Will biotech layoffs continue through 2023?

The mammogram wars are not over

Interest rates are at a 22

Will biotech layoffs continue through 2023?

Public health communication lessons from Covid

‘Oppenheimer’ and the risks of AI in health care

explore

Wikipedia

explore

Trump demands the U.S. pay no more for drugs than other countries … again

National panel will explore requiring free Covid tests

Novavax promises a turnaround & Lilly roils the obesity market

An outrageous hospital charge: I paid $710 for an hour of babysitting

Medicare proposal to cover medical devices draws a mixed reaction

No plane should take off without an EpiPen onboard

23andMe had bad news about my health. I wish a person had delivered it

Interest rates are at a 22

Activists slam private health insurers over coverage restrictions

Ending health disparities requires full federal government, panel says

Wikipedia

CDC: Cases of alpha

Behind warning on Apellis’s eye drug lies a conflict of interest

Ford recalls 870K F

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

Alexander Hamilton and the argument for universal insurance

focus

hotspot

Wikipedia

leisure time